The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

NeuroSigma, Inc. is a medical device company based in Westwood, California. NeuroSigma is focused on commercialization of its unique Trigeminal Nerve Stimulation (TNS) technology, and has a growing pipeline of treatments targeting epilepsy, depression, attention deficit hyperactivity disorder (ADHD), and post-traumatic stress disorder (PTSD). NeuroSigma is actively engaged in cutting-edge preclinical research and development, as well as groundbreaking Phase I, II, & III clinical trials.

Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert in 1950 and headquartered in Irvine, CA.

Orsan Medical Technologies Ltd. is a private company headquartered in Netanya, Israel. The firm develops a non-invasive and automatic device to measure and monitor cerebral blood flow.

Lungpacer Medical is developing a novel therapeutic solution for preserving the integrity and strength of the diaphragm muscle The objective of the company is to develop and commercialize a novel therapeutic solution that addresses the significant health and cost issues associated with mechanical ventilation of critically ill patients in hospital Intensive Care Units (ICU). It is designed to activate the diaphragm using a temporary, minimally invasive, transvascular nerve stimulation approach that is expected to save many lives, improve surviving patient outcomes and greatly reduce hospital care costs. In addition, the paced diaphragm is expected to restore negative pressure ventilation, thereby potentially providing a more physiological respiratory pattern and reducing the levels of positive pressure ventilation and its harmful effects on the lungs. Lung Pacer was founded in 2009 and is headquartered in Vancouver, British Columbia, Canada.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Chiron Corporation (/ˈkaɪrɒn/ KY-ron) was an American multinational biotechnology firm based in Emeryville, California that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.

OptiNose AS develops, produces, administers, commercializes, and distributes exhalation drug delivery systems. It offers single and multi-use intranasal delivery devices for liquid and powder formulations. The company was founded on September 9, 2007 and is headquartered in Oslo, Norway.

The Feinstein Institutes for Medical Research comprise the research arm of Northwell Health. Feinstein is home to 50 research labs, 2,500 clinical research studies, and 4,000 professional and support staff. Feinstein researchers have made breakthroughs in molecular medicine, genetics, cancer, brain research, mental health, autoimmunity and bioelectronic medicine, among others, and continue work in those and other areas. Feinstein is the laboratory and faculty home of the Elmezzi Graduate School of Molecular Medicine. Additionally, students without an MD degree may earn a PhD in molecular medicine via the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, as part of the medical school's MD/PhD or PhD programs.

The United States Department of Veterans Affairs (VA) is a federal Cabinet-level agency that provides near-comprehensive healthcare services to eligible military veterans at VA medical centers and outpatient clinics located throughout the country; several non-healthcare benefits including disability compensation, vocational rehabilitation, education assistance, home loans, and life insurance; and provides burial and memorial benefits to eligible veterans and family members at 135 national cemeteries.

Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ.

Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany.

Pharmaleads aims to provide patients suffering from severe chronic and acute pain with improved pain relief without the side effects associated with other classes of analgesics. Based on years of experience in the design of highly potent and specific inhibitors of enkephalinases, Pharmaleads has developed a new class of analgesics called DENKIs (Dual Enkephalinases inhibitors). These small molecules are able to provide patients with local and sustainable pain relief. Pharmaleads’ DENKIs are first-in-class drugs with a novel mechanism of action tackling pain by using endogenous enkephalins, natural peptides that specifically bind to pain-related opioid receptors to naturally modulate pain without the side effects observed with exogenous opioid drugs that also bind to other opioids receptors, not involved in pain control, triggering multiple side effects. Pharmaleads believes its products can change the lives of the many patients who are in need of improved treatment options for their chronic and/or acute pain, and could offer healthcare providers with an improved pain management option that helps address the opioid epidemic.

Senju Pharmaceutical Beijing Co. Ltd., part of Senju Pharmaceutical Co., Ltd., is a company headquartered in Beijing, China, that manufactures and distributes pharmaceuticals.

Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals. Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals.” In accordance with this philosophy, as we implement our business activities we strive to realize our vision, which expresses that “Mitsubishi Tanabe Pharma strive to be a global research-driven pharmaceutical company that is trusted by communities.” As a company that is trusted and highly evaluated by patients and health care professionals as well as by society and shareholders, we will implement management with a focus on transparency and fairness while always keeping in mind the starting point of our business activities: “Everything we do is for the patients.”

Trigemina, Inc. develops non-opiate drug formulations and delivery systems for the pain therapy. The company’s products include TI-001, an intranasal oxytocin that targets chronic and sub-acute head pain; and TI-002, a non-opioid treatment that addresses a range of pain, including neuropathic pain throughout the body. Its drugs are delivered via the nasal-cerebral pathway. The company was founded in 2006 and is based in Mountain View, California.

Achelios Therapeutics is a pharmaceutical development company that focuses on advancing new product concepts through the 505(b)(2) process to early clinical proof of principle followed by asset (project) sale. Achelios has adopted a semi-virtual model to control costs and advance projects by utilizing its experienced team and on-call external pharmaceutical experts and partners. This allows the company’s management to precisely tailor project needs with the right level of expertise and/or key opinion leaders with influence at the FDA, academic medical centers, and at the level of the payer (insurance company/government).

Shengtaikang Life Science Research (Shandong) Co., Ltd., established on 2018-12-03, Business scope includes life science research;Technology development in the field of medical devices,Technology Promotion,technology transfer,technical consulting,Technical Services;R&D of medical devices,Production,Sales(No country restrictions,Eliminated and outdated products,The production and operation activities can only be carried out after passing the inspection and acceptance of the environmental protection department;The operating permit);Medical market analysis survey service;Sales:metallic material(In addition to exclusive control),building materials,Wujinjiaodian,Ordinary machinery,Electrical machinery and equipment,Instrumentation,Chemical raw materials and products(Free of hazardous chemicals and precursor chemicals),textile,Daily necessities,stationery,Decoration material,profiles,Electrical Equipment,ceramics,office equipment;Operating import and export business(Excluding commodities and technologies that are restricted by the state or prohibited from import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)